| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 1e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |